期刊文献+

黄芪扶正汤对Lewis肺癌荷瘤小鼠血清IL-2、IFN-γ表达的影响 被引量:4

Effect of Huangqi Fuzheng decoction on expression of serum IL-2 and IFN-γ in Lewis lung cancer tumor-bearing mice
下载PDF
导出
摘要 目的探讨黄芪扶正汤对Lewis肺癌小鼠治疗作用的具体机制。方法建立肺癌荷瘤小鼠动物模型,以MTT法测脾脏T淋巴细胞增殖反应,ELISA法测血清IL-2和IFN-γ含量,评价黄芪扶正汤的抗肿瘤和免疫调节的作用,并初步分析其作用机制。结果黄芪扶正汤可以提高肺癌小鼠的脾脏指数,而对其T淋巴细胞增殖的能力基本影响不大。联合化疗处理组小鼠体内的IL-2、IFN-γ上升。结论黄芪扶正汤可以通过上调血清IL-2、IFN-γ的含量来提高其免疫功能,从而发挥可能的抗肿瘤作用。 Objective It is to approach the mechanism of Huangqi Fuzheng decoction(HQFZ) on Lewis mice with lung cancer.Methods The model of tumor-bearing mice was made,and then T-lymphocyte proliferation was measured by MTT,and contents of IL-2 and IFN-γ were measured by ELISA.The effects of anti-cancer and immunoloregulation of HQFZ were evaluated and the mechanism of action was analyzed.Results The spleen index of tumor-bearing mice was increased by treating with HQFZ,but the influence of HQFZ on T lymphocyte proliferation was little.The levels of serum IL-2 and IFN-γ of mice in DDP plus HQFZ group were increased.Conclusion HQFZ can improve immune function by up-regulate the levels of serum IL-2 and IFN-γ,this may play a role in anti-tumor effect.
出处 《现代中西医结合杂志》 CAS 2012年第15期1619-1621,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 黄芪扶正汤 顺铂 肺癌 T淋巴细胞 细胞因子 Huangqi Fuzheng decoction Cisplatin lung cancer T-lymphocyte cytokine
  • 相关文献

参考文献10

  • 1Kaira K,Oriuchi N,Sunaga N, et al. A systemic review of PET and biology in lun cancer[J]. Am J Transl Res,2011,3 (4) :383 - 391.
  • 2Kubota K,Murakami K, Inoue T, et al. Additional value of FDG- PET to contrast enhanced-computed tomography (CT) for the diag- nosis of mediastinal lymph node metastasis in non-small cell lungcancer: a Japanese multicenter clinical study [ J ]. Ann Nucl Med, 2011,25(10) :777 -786.
  • 3Kashkin KN,Musatkina EA,KomeIkov AV ,et al. Genes potentially associated with cisplatin resistance of lung cancer cells [ J ]. Dokl Biochem Biophys,2011,438 : 147 - 150.
  • 4Zheng D, Haddadin S, Wang Y,et al. Plasma microRNAs as novel biomarkers for early detection of lung cancer [ J]. Int J Clin Exp Pathol,20 l 1,4 (6) :575 - 586.
  • 5Shepherd FA, Douillard JY, Blumenschein GJ. Immunotherapy for non-small cell lung cancer: novel approaches to improve patient out- come[ J ]. J Thorac Oncol,2011,6 (10) : 1763 - 1773.
  • 6Coate LE,Shepherd FA. Maintenance therapy in advanced non - small cell lung cancer: evolution,tolerability and outcomes[ J ]. T- her Adv Med Oncol,2011,3 (3) : 139 - 157.
  • 7Kato T,Fujino H,Oyama S,et al. Indomethacin induces cellular mor- phological change and migration via epithelial-mesenchymal transi- tion in A549 human lung cancer cells:A novel cyclooxygenase-inhi- bition-independent effect[ J ]. Biochem Pharmacol, 2011,82 ( 11 ) : 1781 - 1791.
  • 8Serrano D, Bleau AM, Fernandez-Garcia I, et al. Inhibition of telom- erase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer [ J ]. Mol Cancer,20 i 1,10:96.
  • 9Sattler M, Reddy MM, Hasina R, et al. The role of the c-Met path- way in lung cancer and the potential for targeted therapy[ J ]. Ther Adv Med Oncol,2011,3(4) :171 - 184.
  • 10Cao J, Chen C,Zeng L, et al. Elevated plasma IL - 22 levels correla- ted with Thl and Th22 cells in patients with immune thromboeytope- nia[J]. Clin Immunol,2011,14(1) :121-123.

同被引文献52

引证文献4

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部